A Novel Tumor Progression Prediction Method for Multimode Ablation Treatment.
IEEE Transactions on Bio-Medical Engineering
|September 30, 2021
Summary
A new method predicts liver cancer progression after multimode ablation therapy using thermal dose data. This approach improves postoperative evaluation and prognosis, aiding personalized medicine.
Area of Science:
- Oncology
- Medical Imaging
- Data Science
Background:
- Multimode ablation (radio-frequency heating post-pre-freezing) shows promise for liver cancer treatment, enhancing therapeutic effects and anti-tumor immunity.
- Post-treatment, ablated lesions remain, necessitating accurate methods for immediate outcome assessment and long-term disease monitoring.
Purpose of the Study:
- To develop a novel method for predicting tumor progression after multimode ablation for liver cancer.
- To enable simultaneous postoperative evaluation and prognosis analysis.
Main Methods:
- Leveraging intraoperative therapeutic information from thermal dose distribution.
- Developing a survival analysis framework using features from clinical, preoperative, intraoperative, and postoperative data.
- Employing random survival forest for feature selection and deep neural networks for survival prediction.
Main Results:
- The proposed method achieved a C-index of 0.855±0.090, outperforming existing state-of-the-art survival analysis techniques.
- Thermal dose information was a significant predictor, accounting for 21.7% of the overall feature importance.
Conclusions:
- The developed data-driven methods are effective for tumor progression prediction in multimode ablation therapy.
- This approach can benefit personalized medicine and streamline patient follow-up processes.


